10x Genomics (TXG) Other Gross PP&E Adjustments (2018 - 2026)

10x Genomics' Other Gross PP&E Adjustments history runs 9 years deep, the most recent figure standing at $323.1 million for Q1 2026.

• In Q1 2026, Other Gross PP&E Adjustments changed 0.47% year-over-year to $323.1 million; the TTM figure through Mar 2026 stood at $323.1 million (changed 0.47% YoY), while the FY2025 annual figure was $295.3 million, up 1.3% from the prior year.
• Other Gross PP&E Adjustments came in at $323.1 million for Q1 2026 at 10x Genomics, up from $295.3 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $323.8 million in Q3 2024 to a low of -$75.7 million in Q1 2022.
• A 5-year average of $217.5 million and a median of $299.4 million in 2023 frame the typical range for Other Gross PP&E Adjustments.
• Across the five-year window, Other Gross PP&E Adjustments slumped 190.35% in 2022 and soared 535.6% in 2023, its largest moves.
• 10x Genomics' Other Gross PP&E Adjustments stood at $267.4 million in 2022, then gained by 9.72% to $293.4 million in 2023, then retreated by 0.62% to $291.6 million in 2024, then climbed by 1.3% to $295.3 million in 2025, then rose by 9.41% to $323.1 million in 2026.
• According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered $323.1 million, $295.3 million, and $314.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison